{"id":"W3188131079","doi":"10.1016/s1470-2045(21)00342-9","title":"Chemotherapy with or without avelumab followed by avelumab maintenance versus chemotherapy alone in patients with previously untreated epithelial ovarian cancer (JAVELIN Ovarian 100): an open-label, randomised, phase 3 trial","year":2021,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":284,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Merck KGaA; Array BioPharma; Russian Academy of Sciences; Pfizer","keywords":"Avelumab; Javelin; Medicine; Chemotherapy; Ovarian cancer; Epithelial ovarian cancer; Oncology; Internal medicine; Open label; Cancer; Immunotherapy; Clinical trial; Pembrolizumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008649299,0.0006811639,0.002479112,0.00009814853,0.0002220113,0.0001345839,0.0006133649,0.0003194667,0.001603496],"category_scores_gemma":[0.00009613627,0.0003818119,0.00008471129,0.0007476641,0.0002919586,0.0002337646,0.00008655756,0.0005572533,0.00001878269],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001269346,"about_ca_system_score_gemma":0.00252793,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002190265,"about_ca_topic_score_gemma":0.007155204,"domain_scores_codex":[0.9957504,0.0006984839,0.0007784779,0.001158033,0.0005326753,0.001081989],"domain_scores_gemma":[0.9971606,0.0003248421,0.0005415187,0.001276623,0.0003621315,0.0003343266],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9306635,0.01323315,0.009345897,0.00004365537,0.001774848,0.0004499346,0.00163774,0.000008413721,0.0003372693,0.0000670336,0.005162922,0.03727558],"study_design_scores_gemma":[0.9314685,0.03298503,0.00497527,0.0003311785,0.0007443171,0.00005380706,0.0001533895,0.0001722824,0.001626553,0.0000229768,0.02692116,0.0005454638],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9704117,0.0003363674,0.0001945592,0.01842793,0.0005784773,0.008290516,0.0003167873,0.0001088807,0.001334789],"genre_scores_gemma":[0.9780209,0.001646911,0.005258389,0.007877458,0.001056382,0.002986996,0.0007297607,0.0002222468,0.002200962],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03673012,"threshold_uncertainty_score":0.9998634,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05096597704849702,"score_gpt":0.3713370121621499,"score_spread":0.3203710351136529,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}